FDAnews Drug Daily Bulletin

UNIGENE ANNOUNCES RESULTS FOR THE FIRST QUARTER OF 2006

May 12, 2006
A A

Unigene Laboratories, Inc. announced its financial results for the quarter ended March 31, 2006. Revenue for the quarter ended March 31, 2006 was $387,000 compared to $588,000 for the quarter ended March 31, 2005. Unigene's net loss for the quarter ended March 31, 2006 was $3,243,000 or ($.04) per share compared to a net loss of $3,254,000 or ($.04) per share for the quarter ended March 31, 2005.
Genetic Engineering News